A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial results.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Attia, S; Bolejack, V; Ganjoo, KN; George, S; Agulnik, M; Rushing, DA; Loggers, ET; Livingston, MB; Wright, JA; Chawla, SP; Okuno, SH; Reinke, DK; Riedel, RF; Davis, LE; Ryan, CW; Maki, RG

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 11005 - 11005

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.11005